Mivazerol or piroximone
- Level
- Commodity
- Parent
- 51392200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51392211This classification denotes an alpha-adrenergic agonist with the molecular formula C11H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W5P1SSA8KD, chemically known as alpha-imidazol-4-yl-2,3-cresotamide but generally known as mivazerol, which bears US NIH Compound Identifier 60784. European Medicines Agency schedules Mivazerol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09015MIG. The term MIVAZEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). Mivazerol or piroximone bears US NLM identifiers UMLS ID C0071150 and NCI Concept Code C90921. SMILES: CCC1=C(NC(=O)N1)C(=O)C2=CC=NC=C2.
Same parent
Under 51392200 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.